California State Teachers Retirement System (CalSTRS)’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$612K Sell
136,933
-1,647
-1% -$7.66K ﹤0.01% 1992
2025
Q4
$762K Buy
138,580
+128,207
+1,236% +$623K ﹤0.01% 1912
2025
Q3
$33.9K Sell
10,373
-2,262
-18% -$6.4K ﹤0.01% 2370
2025
Q2
$29.2K Hold
12,635
﹤0.01% 2386
2025
Q1
$17.6K Hold
12,635
﹤0.01% 2574
2024
Q4
$21.9K Hold
12,635
﹤0.01% 2574
2024
Q3
$25.4K Buy
12,635
+1,044
+9% +$2.29K ﹤0.01% 2530
2024
Q2
$26K Buy
+11,591
New +$33.7K ﹤0.01% 2517
2022
Q2
Sell
-24,435
Closed -$159K 3302
2022
Q1
$159K Sell
24,435
-2,255
-8% -$16.9K ﹤0.01% 2722
2021
Q4
$311K Buy
26,690
+736
+3% +$11.1K ﹤0.01% 2666
2021
Q3
$483K Sell
25,954
-4,758
-15% -$90.4K ﹤0.01% 2472
2021
Q2
$651K Buy
30,712
+17,584
+134% +$405K ﹤0.01% 2492
2021
Q1
$266K Hold
13,128
﹤0.01% 2785
2020
Q4
$348K Buy
+13,128
New +$283K ﹤0.01% 2592

Other funds holding TSHA

California State Teachers Retirement System (CalSTRS)'s TSHA Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Taysha Gene Therapies (TSHA) stake by 1.2% in Q1 2026, selling an estimated $7.66K and leaving 136,933 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #1992.

California State Teachers Retirement System (CalSTRS) first reported a position in TSHA in Q4 2020 and has held it in 14 quarters since. The position peaked at $762K in Q4 2025. 191 funds tracked by Wall St. Rank hold TSHA as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 136,933 shares of Taysha Gene Therapies worth $612K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 1,647 Taysha Gene Therapies shares in Q1 2026, an estimated $7.66K.
  • Taysha Gene Therapies made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1992 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Taysha Gene Therapies in Q4 2020 and has held it in 14 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Taysha Gene Therapies position peaked at $762K in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.